Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase IIb study of Allocetra in primary Knee OsteoArthritis patients

Next Previous
Trial Profile

Phase IIb study of Allocetra in primary Knee OsteoArthritis patients

Status: Planning
Phase of Trial: Phase II

Latest Information Update: 11 Dec 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 24 Nov 2025 According to an Enlivex media release, the company plans to initiate this trial in 1H 2026.
  • 06 Nov 2025 New trial record
  • 29 Sep 2025 According to an Enlivex media release, the company will participate in a live investor webinar hosted by D. Boral Capital on September 30, 2025, at 10:00 AM Eastern Time. The discussion will bring together leading key opinion leaders (KOLs) in musculoskeletal disease, alongside Enlivex Vice Chairman and D. Boral Research Director.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top